Ergoteles LLC Champions Oncology, Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.21 - $9.47 $100,485 - $131,983	13,937 New	13,937 $105,000
Q4 2021 Feb 14, 2022	SELL	$7.76 - $10.23 $237,184 - $312,679	-30,565 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$9.11 - $10.96 $3,051 - $3,671	-335 Reduced 1.08%	30,565 $312,000
Q2 2021 Aug 12, 2021	BUY	$8.45 - $11.72 $261,104 - $362,148	30,900 New	30,900 $318,000

5.81M

3.3K

6.1K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $53.7M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.